Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma

Hyung Soon Park; Yu Jin Kim; Woo Ick Yang; Chang Ok Suh; Yong Chan Lee

doi:10.3748/wjg.v16.i17.2158

Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma

Hyung Soon Park, Yu Jin Kim, Woo Ick Yang, Chang Ok Suh, Yong Chan Lee

Research output: Contribution to journal › Article › peer-review

40 Citations (Scopus)

Abstract

AIM: To investigate treatment outcome of Helicobacter pylori (H. pylori)-negative low-grade gastric mucosa-associated lymphoid tissue (MALT) lymphoma. METHODS: In this study, we retrospectively reviewed the clinical outcome and clinicopathologic factors of stage IE H. pylori-negative low-grade gastric MALT lymphoma cases from August 1998 to June 2009. RESULTS: A total of eleven patients with H. pylori-negative low-grade gastric MALT lymphoma were enrolled in the study and received anti-H. pylori eradication treatment and/or radiotherapy or excisional therapy. Complete remission (CR) of gastric MALT lymphoma was achieved in all patients. The time to CR was 1-66 mo (median, 1 mo). CONCLUSION: Eradication therapy may be offered as an initial treatment option even in cases of localized H. pylori-negative gastric MALT lymphoma.

Original language	English
Pages (from-to)	2158-2162
Number of pages	5
Journal	World Journal of Gastroenterology
Volume	16
Issue number	17
DOIs	https://doi.org/10.3748/wjg.v16.i17.2158
Publication status	Published - 2010

All Science Journal Classification (ASJC) codes

Gastroenterology

Access to Document

10.3748/wjg.v16.i17.2158

Cite this

@article{a2d65c35e8454fa3ba660e9deeb3a410,

title = "Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma",

abstract = "AIM: To investigate treatment outcome of Helicobacter pylori (H. pylori)-negative low-grade gastric mucosa-associated lymphoid tissue (MALT) lymphoma. METHODS: In this study, we retrospectively reviewed the clinical outcome and clinicopathologic factors of stage IE H. pylori-negative low-grade gastric MALT lymphoma cases from August 1998 to June 2009. RESULTS: A total of eleven patients with H. pylori-negative low-grade gastric MALT lymphoma were enrolled in the study and received anti-H. pylori eradication treatment and/or radiotherapy or excisional therapy. Complete remission (CR) of gastric MALT lymphoma was achieved in all patients. The time to CR was 1-66 mo (median, 1 mo). CONCLUSION: Eradication therapy may be offered as an initial treatment option even in cases of localized H. pylori-negative gastric MALT lymphoma.",

author = "Park, {Hyung Soon} and Kim, {Yu Jin} and Yang, {Woo Ick} and Suh, {Chang Ok} and Lee, {Yong Chan}",

year = "2010",

doi = "10.3748/wjg.v16.i17.2158",

language = "English",

volume = "16",

pages = "2158--2162",

journal = "World Journal of Gastroenterology",

issn = "1007-9327",

publisher = "WJG Press",

number = "17",

}

TY - JOUR

T1 - Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma

AU - Park, Hyung Soon

AU - Kim, Yu Jin

AU - Yang, Woo Ick

AU - Suh, Chang Ok

AU - Lee, Yong Chan

PY - 2010

Y1 - 2010

N2 - AIM: To investigate treatment outcome of Helicobacter pylori (H. pylori)-negative low-grade gastric mucosa-associated lymphoid tissue (MALT) lymphoma. METHODS: In this study, we retrospectively reviewed the clinical outcome and clinicopathologic factors of stage IE H. pylori-negative low-grade gastric MALT lymphoma cases from August 1998 to June 2009. RESULTS: A total of eleven patients with H. pylori-negative low-grade gastric MALT lymphoma were enrolled in the study and received anti-H. pylori eradication treatment and/or radiotherapy or excisional therapy. Complete remission (CR) of gastric MALT lymphoma was achieved in all patients. The time to CR was 1-66 mo (median, 1 mo). CONCLUSION: Eradication therapy may be offered as an initial treatment option even in cases of localized H. pylori-negative gastric MALT lymphoma.

AB - AIM: To investigate treatment outcome of Helicobacter pylori (H. pylori)-negative low-grade gastric mucosa-associated lymphoid tissue (MALT) lymphoma. METHODS: In this study, we retrospectively reviewed the clinical outcome and clinicopathologic factors of stage IE H. pylori-negative low-grade gastric MALT lymphoma cases from August 1998 to June 2009. RESULTS: A total of eleven patients with H. pylori-negative low-grade gastric MALT lymphoma were enrolled in the study and received anti-H. pylori eradication treatment and/or radiotherapy or excisional therapy. Complete remission (CR) of gastric MALT lymphoma was achieved in all patients. The time to CR was 1-66 mo (median, 1 mo). CONCLUSION: Eradication therapy may be offered as an initial treatment option even in cases of localized H. pylori-negative gastric MALT lymphoma.

UR - http://www.scopus.com/inward/record.url?scp=77952500811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952500811&partnerID=8YFLogxK

U2 - 10.3748/wjg.v16.i17.2158

DO - 10.3748/wjg.v16.i17.2158

M3 - Article

C2 - 20440857

AN - SCOPUS:77952500811

SN - 1007-9327

VL - 16

SP - 2158

EP - 2162

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

IS - 17

ER -

Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this